glp-1 analogue medication Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response GLP-1 Agonists Market Report 2025-2033,

That paved the way for drugs like semaglutide (Ozempic), which was approved in 2017 and is administered just once a week, making it much easier to use

The various approaches include the combination of GLP-1R agonists with leptin [912,913], salmon calcitonin [914], PYY [915], CCK [916], insulin [917], adrenomedullin [918], and 3-adrenergic receptor agonists [919], and antagonists at the cannabinoid receptor 1 (CB1) [920], or agonists at the receptors for melanocortin-4 (MC4R) [685] or farnesoid-x (FXR) [921]

However, most research has used experimental models, with limited clinical data, although significant trials are ongoing

doi: 10.1530/JOE-11-0094 52 MasurKTibaduizaECChenCLigonBBeinbornM

Gut peptides and postprandial satiety